Caricamento...
Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia
BACKGROUND: The muscarinic receptor agonist xanomeline has antipsychotic properties and is devoid of dopamine receptor–blocking activity but causes cholinergic adverse events. Trospium is a peripherally restricted muscarinic receptor antagonist that reduces peripheral cholinergic effects of xanomeli...
Salvato in:
| Pubblicato in: | N Engl J Med |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7610870/ https://ncbi.nlm.nih.gov/pubmed/33626254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2017015 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|